
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Pim Hermans is Director of Ligand Discovery, Bioproduction at Thermo Fisher Scientific (Leiden, The Netherlands).
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Published: September 15th 2017 | Updated: